The authors of the latter study found an intriguing co-expression of the immune checkpoint protein programmed cell death protein 1 (PD1) with CD39 in patients with tumor relapse, suggesting a role of CD39 in tumor-related immunoevasive mechanisms. This evidence concerns the gene ENTPD1 and neoplasm.